Nxera Pharma Co., Ltd. (FRA:JSS)
Germany · Delayed Price · Currency is EUR 4.780
+0.280 (6.22%)
At close: Nov 28, 2025
Nxera Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -6,144 | -4,662 | -10,680 | 1,078 | 433 | 1,622 | Upgrade |
Depreciation & Amortization | 4,286 | 3,984 | 2,478 | 1,345 | 1,278 | 1,350 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | 3,138 | - | Upgrade |
Loss (Gain) From Sale of Investments | 5 | 5 | 1,363 | 1,877 | -208 | -111 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | 429 | -50 | 356 | Upgrade |
Other Operating Activities | -2,539 | 28 | -942 | 338 | 486 | 1,325 | Upgrade |
Change in Accounts Receivable | -2,748 | -742 | 1,315 | -210 | -799 | 752 | Upgrade |
Change in Inventory | -8,000 | -5,935 | 1,908 | - | - | - | Upgrade |
Change in Accounts Payable | 1,939 | -487 | 1,552 | 315 | -184 | 61 | Upgrade |
Change in Other Net Operating Assets | -162 | 91 | -2,267 | 4,780 | 3,001 | -683 | Upgrade |
Operating Cash Flow | -13,513 | -7,718 | -5,273 | 9,952 | 7,095 | 4,672 | Upgrade |
Operating Cash Flow Growth | - | - | - | 40.27% | 51.86% | 35.77% | Upgrade |
Capital Expenditures | -454 | -526 | -804 | -277 | -193 | -92 | Upgrade |
Cash Acquisitions | - | - | -62,941 | - | - | - | Upgrade |
Divestitures | -379 | - | - | - | 206 | -577 | Upgrade |
Sale (Purchase) of Intangibles | -1,158 | -1,011 | -47 | -26 | -8 | -13 | Upgrade |
Investment in Securities | 23 | -3,870 | - | 1,209 | - | 238 | Upgrade |
Other Investing Activities | 490 | 644 | 1 | 137 | 273 | 294 | Upgrade |
Investing Cash Flow | -1,478 | -4,763 | -63,791 | 1,043 | 278 | -150 | Upgrade |
Long-Term Debt Issued | - | - | 71,608 | - | 29,855 | 15,902 | Upgrade |
Long-Term Debt Repaid | - | -5,800 | -1,450 | - | - | - | Upgrade |
Total Debt Repaid | -6,698 | -5,800 | -1,450 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | -6,698 | -5,800 | 70,158 | - | 29,855 | 15,902 | Upgrade |
Issuance of Common Stock | - | - | 9,983 | - | 600 | 5,145 | Upgrade |
Other Financing Activities | - | -1,054 | -31,812 | -4,887 | -19,332 | -769 | Upgrade |
Financing Cash Flow | -6,698 | -6,854 | 48,329 | -4,887 | 11,123 | 20,278 | Upgrade |
Foreign Exchange Rate Adjustments | 1,282 | 2,538 | 3,243 | 362 | 1,583 | -167 | Upgrade |
Net Cash Flow | -20,407 | -16,797 | -17,492 | 6,470 | 20,079 | 24,633 | Upgrade |
Free Cash Flow | -13,967 | -8,244 | -6,077 | 9,675 | 6,902 | 4,580 | Upgrade |
Free Cash Flow Growth | - | - | - | 40.18% | 50.70% | 44.48% | Upgrade |
Free Cash Flow Margin | -48.67% | -28.59% | -47.60% | 62.14% | 38.97% | 51.80% | Upgrade |
Free Cash Flow Per Share | -154.97 | -91.87 | -73.65 | 117.14 | 84.17 | 57.62 | Upgrade |
Cash Interest Paid | 504 | 435 | 241 | 171 | 157 | 60 | Upgrade |
Cash Income Tax Paid | - | 269 | 1,394 | 262 | -87 | -1,170 | Upgrade |
Levered Free Cash Flow | -12,520 | -9,249 | -11,530 | -1,367 | 8,544 | 4,514 | Upgrade |
Unlevered Free Cash Flow | -11,324 | -8,768 | -11,038 | -946.5 | 8,868 | 4,644 | Upgrade |
Change in Working Capital | -10,916 | -7,073 | 2,508 | 4,885 | 2,018 | 130 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.